相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Multicenter Evaluation of [-2]Proprostate-Specific Antigen and the Prostate Health Index for Detecting Prostate Cancer
Carsten Stephan et al.
CLINICAL CHEMISTRY (2013)
Comparative Assessment of Urinary Prostate Cancer Antigen 3 and TMPRSS2:ERG Gene Fusion with the Serum [-2]Proprostate-Specific Antigen-Based Prostate Health Index for Detection of Prostate Cancer
Carsten Stephan et al.
CLINICAL CHEMISTRY (2013)
Serum Isoform [-2]proPSA Derivatives Significantly Improve Prediction of Prostate Cancer at Initial Biopsy in a Total PSA Range of 2-10 ng/ml: A Multicentric European Study
Massimo Lazzeri et al.
EUROPEAN UROLOGY (2013)
Initial Prostate Biopsy: Development and Internal Validation of a Biopsy-specific Nomogram Based on the Prostate Cancer Antigen 3 Assay
Jens Hansen et al.
EUROPEAN UROLOGY (2013)
Head-to-Head Comparison of Prostate Health Index and Urinary PCA3 for Predicting Cancer at Initial or Repeat Biopsy
Vincenzo Scattoni et al.
JOURNAL OF UROLOGY (2013)
Prostate health index (phi) and prostate cancer antigen 3 (PCA3) significantly improve diagnostic accuracy in patients undergoing prostate biopsy
Sisto Perdona et al.
PROSTATE (2013)
The value of urinary prostate cancer gene 3 (PCA3) scores in predicting pathological features at radical prostatectomy
Xavier Durand et al.
BJU INTERNATIONAL (2012)
Predicting prostate biopsy outcome: prostate health index (phi) and prostate cancer antigen 3 (PCA3) are useful biomarkers
Matteo Ferro et al.
CLINICA CHIMICA ACTA (2012)
Preoperative Prostate-Specific Antigen Isoform p2PSA and Its Derivatives, %p2PSA and Prostate Health Index, Predict Pathologic Outcomes in Patients Undergoing Radical Prostatectomy for Prostate Cancer
Giorgio Guazzoni et al.
EUROPEAN UROLOGY (2012)
Association of [-2]proPSA with Biopsy Reclassification During Active Surveillance for Prostate Cancer
Jeffrey J. Tosoian et al.
JOURNAL OF UROLOGY (2012)
Prostate-Specific Antigen (PSA) Isoform p2PSA Significantly Improves the Prediction of Prostate Cancer at Initial Extended Prostate Biopsies in Patients with Total PSA Between 2.0 and 10 ng/ml: Results of a Prospective Study in a Clinical Setting
Giorgio Guazzoni et al.
EUROPEAN UROLOGY (2011)
Contemporary Role of Prostate Cancer Antigen 3 in the Management of Prostate Cancer
Marco Auprich et al.
EUROPEAN UROLOGY (2011)
A Multicenter Study of [-2]Pro-Prostate Specific Antigen Combined With Prostate Specific Antigen and Free Prostate Specific Antigen for Prostate Cancer Detection in the 2.0 to 10.0 ng/ml Prostate Specific Antigen Range
William J. Catalona et al.
JOURNAL OF UROLOGY (2011)
ProPSA and Diagnostic Biopsy Tissue DNA Content Combination Improves Accuracy to Predict Need for Prostate Cancer Treatment Among Men Enrolled in an Active Surveillance Program
Sumit Isharwal et al.
UROLOGY (2011)
Short-term outcomes of the prospective multicentre 'Prostate Cancer Research International: Active Surveillance' study
Roderick C. N. van den Bergh et al.
BJU INTERNATIONAL (2010)
Pre-analytical in-vitro stability of [-2]proPSA in blood and serum
Axel Semjonow et al.
CLINICAL BIOCHEMISTRY (2010)
External Validation of Urinary PCA3-Based Nomograms to Individually Predict Prostate Biopsy Outcome
Marco Auprich et al.
EUROPEAN UROLOGY (2010)
Accuracy of PCA3 Measurement in Predicting Short-Term Biopsy Progression in an Active Surveillance Program
Jeffrey J. Tosoian et al.
JOURNAL OF UROLOGY (2010)
A note on adaptive Bonferroni and Holm procedures under dependence
Wenge Guo
BIOMETRIKA (2009)
Standard Operating Procedures for Serum and Plasma Collection: Early Detection Research Network Consensus Statement Standard Operating Procedure Integration Working Group
Melissa K. Tuck et al.
JOURNAL OF PROTEOME RESEARCH (2009)
Decision curve analysis: A novel method for evaluating prediction models
Andrew J. Vickers et al.
MEDICAL DECISION MAKING (2006)
APTIMA PCA3 molecular urine test: Development of a method to aid in the diagnosis of prostate cancer
Jack Groskopf et al.
CLINICAL CHEMISTRY (2006)
Pathological characteristics of prostate cancer detected through prostate specific antigen based screening
S Loeb et al.
JOURNAL OF UROLOGY (2006)
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
JI Epstein et al.
AMERICAN JOURNAL OF SURGICAL PATHOLOGY (2005)
分享论文
